Listen as Michael S. Blaiss, MD provides case-based perspectives on chronic cough recognition, burden, management, and pathophysiology and describes the evolving treatment landscape for refractory chronic cough.

Presenter
Michael S. Blaiss, MD
Clinical Professor of Pediatrics
Division of Allergy-Immunology
Medical College of Georgia at Augusta University
Augusta, Georgia

Link to full program: 
https://bit.ly/4kweynG

Listen in as Paula Henao, MD; Rohit Loomba, MD, MHSc; Cheryl Pirozzi, MD, MS; and Corinne Young, NP, FCCP, discuss their screening and monitoring strategies for patients with alpha-1 antitrypsin deficiency, including:

• Why early detection is key for improving patient outcomes
• How to monitor through use of noninvasive imaging and biopsy per guideline recommendations
• How to coordinate patient care to provide much-needed multidisciplinary care
• What therapies in the pipeline could transform the treatment landscape for this genetic disease
   

Presenters

Paula Henao, MD
Assistant Professor of Medicine
Division of Pulmonary, Allergy and Critical Care Medicine
Penn State Hershey Medical Center
Hershey, Pennsylvania

Rohit Loomba, MD, MHSc
Professor of Medicine
Chief, Division of Gastroenterology and Hepatology
Director, MASLD Research Center
University of California, San Diego
San Diego, California

Cheryl Pirozzi, MD, MS
Associate Professor of Internal Medicine
Division of Pulmonary and Critical Care Medicine
University of Utah
Salt Lake City, Utah

Corinne Young, NP, FCCP
President/Founder
Association of Pulmonary Advanced Practice Providers
Colorado Springs, Colorado

Link to full program: 
https://bit.ly/4dgCRnq

Listen in as Joseph Kim, MD, MPH, MBA, interviews Sejal Desai, MD, DABOM, to learn about how she implemented virtual support groups to improve obesity care at her practice, including:

• Dedicating 5 support groups with chat features to obesity-specific topics (eg, sleep, nonscale wins)
• Moderating these chats to ensure no misinformation is shared and a positive, safe space is maintained
• Expanding to include other virtual options that allow patients to engage more in their care
• Utilizing free and subscription-based services to aid in marketing efforts
• Sharing lessons learned for those interested in implementing similar virtual options for their patients
   

Presenters

Joseph Kim, MD, MPH, MBA
President
Q Synthesis, LLC
Newtown, Pennsylvania

Sejal Desai, MD, DABOM
Board-Certified Obesity Medicine Physician
Owner & Medical Director
Tula Medical Weight Loss & Wellness
Katy, Texas

Link to full program: 
https://clinicaloptions.com/content/qi-resource-hub

Listen in as Joseph Kim, MD, MPH, MBA, interviews Sophia Kwon, MD, to learn about how she implemented a documentation shortcut at her institution to improve obesity care, including:

• Creating an obesity checklist within the electronic health record
• Training staff to correctly use this checklist and broach obesity topics with patients
• Garnering feedback to ensure this checklist did not add to note fatigue or burnout among staff
• Sharing lessons learned for others interested in implementing a similar documentation shortcut

Presenter
Joseph Kim, MD, MPH, MBA
President
Q Synthesis, LLC
Newtown, Pennsylvania 

Sophia Kwon, MD
Internal Medicine Attending
Riverside University Health System Attending
Loma Linda University Health Associate Faculty
Loma Linda, California

Link to full program: 
https://clinicaloptions.com/content/qi-resource-hub

In this episode, Dr Gideon Hirschfield meets with patient advocate Jess Schnur to discuss challenges related to the diagnosis and management of primary biliary cholangitis (PBC) to provide actionable strategies for healthcare professionals to incorporate into patient care, including:

• Disease concerns and frequently asked questions from a patient perspective
• Managing symptoms
• Treatment options and supportive care
• Importance of awareness and education

Presenters:
Gideon Hirschfield, MA, MB BChir, FRCP, PhD
Lily and Terry Horner Chair in Autoimmune Liver Disease Research
Professor, Division of Gastroenterology and Hepatology
University of Toronto
Director, The Autoimmune and Rare Liver Disease Programme
Director, Francis Family Liver Clinic
Toronto General Hospital, University Health Network
Ontario, Canada

Jess N. Schnur, BSN-RN
National PBC Patient Advocate
American Liver Foundation
Donation Support Services Coordinator
Lifeline of Ohio
Columbus, Ohio

To learn more, see the program Hear Me: Patient Perspectives on PBC

In this podcast, expert faculty, Dr Stuart Gordon and Dr Nancy Reau, use an illustrative patient case to explore the roles of ALP and other biochemical markers in PBC management, and explain what to expect from treatment. Topics covered include: 

• How baseline ALP can affect ALP normalization after second-line treatment with elafibranor and seladelpar
• Potential outcomes if ALP normalization cannot be achieved
• The importance of managing fatigue, pruritus, and sleep disturbances independently of the biochemical response

Presenters:

Stuart C. Gordon, MD
Professor of Medicine
Wayne State University School of Medicine
Director, Division of Hepatology
Henry Ford Health
Detroit, Michigan

Nancy Reau, MD
Professor of Medicine
Richard B. Capps Chair of Hepatology
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Rush University Medical Center
Chicago, Illinois

To learn more about PBC management, check out our program, Curbside Consults: Expert Insights on Challenges in PBC Management.  

In this podcast, expert faculty, Dr Stuart Gordon and Dr Nancy Reau discuss an illustrative patient case to demonstrate how they individualize primary biliary cholangitis (PBC) therapy for patients ​with cirrhosis. Topics covered include:

• AASLD guideline recommendations for second-line therapy for PBC
• Considerations when using newer agents for second-line treatment of PBC in patients with cirrhosis: elafibranor and seladelpar

Presenters:

Stuart C. Gordon, MD 
Professor of Medicine
Wayne State University School of Medicine
Director, Division of Hepatology
Henry Ford Health
Detroit, Michigan

Nancy Reau, MD 
Professor of Medicine
Richard B. Capps Chair of Hepatology
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Rush University Medical Center
Chicago, Illinois

To learn more about PBC management, check out our program, 
Curbside Consults: Expert Insights on Challenges in PBC Management.

In this podcast, listen as experts Alan Bonder, MD, AGAF, and Aparna Goel, MD, discuss how they assess the symptoms of primary biliary cholangitis (PBC) and explore how new therapeutic agents may help alleviate symptom burden. Topics include:

• Strategies and tools for assessing pruritus
• Nonpharmacologic and pharmacologic management of pruritus
• Second-line agents and their impact on pruritus
• Investigational treatments for pruritus

Presenters:

Alan Bonder, MD, AGAF
Associate Professor of Medicine
Medical Director of Liver Transplant
Department of Gastroenterology
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts

Aparna Goel, MD
Associate Clinical Professor of Medicine
Division of Gastroenterology and Hepatology
Stanford University
Palo Alto, California

Content based on an online CME program supported by independent educational grants from Gilead Sciences, Inc., and Ipsen Biopharmaceuticals, Inc​.

To learn more about PBC management, check out our program, Curbside Consults: Expert Insights on Challenges in PBC Management.

How do you decide when to move from first-line to second-line treatment for primary biliary cholangitis (PBC)? In this podcast, listen as experts Alan Bonder, MD, AGAF, and Aparna Goel, MD, discuss this question and more, including:

• How and when to measure treatment response
• Evidence-based goals of therapy
• Considerations for second-line treatment
• New agents for second-line treatment: PPAR agonists

Presenters:

Alan Bonder, MD, AGAF
Associate Professor of Medicine
Medical Director of Liver Transplant
Department of Gastroenterology
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts

Aparna Goel, MD
Associate Clinical Professor of Medicine
Division of Gastroenterology and Hepatology
Stanford University
Palo Alto, California

Content based on an online CME program supported by independent educational grants from Gilead Sciences, Inc., and Ipsen Biopharmaceuticals, Inc​.

To learn more about PBC management, check out our program, 
Curbside Consults: Expert Insights on Challenges in PBC Management.

Supported by educational grants from Gilead Sciences, Inc. and Ipsen Biopharmaceuticals, Inc

In this podcast, Sonal Kumar, MD, MPH, meets with patient advocate Maria Morais to discuss actionable steps that healthcare providers can incorporate into the care of people with primary biliary cholangitis (PBC). Listen as they discuss:

• The chronic nature of PBC
• Going beyond biochemical markers to assess and address symptoms such as fatigue and pruritus
• The importance of referral to patient support groups

Presenters:

Sonal Kumar, MD, MPH
Assistant Professor of Medicine
Director, General Gastroenterology and Hepatology
Weill Cornell Medical College
New York, New York

Maria G. Morais, RN
VP Patient Advocacy
Canadian PBC Society
Toronto, Canada

To learn more, see the program Hear Me: Patient Perspectives on PBC